Below are the most recent publications written about "Hyperplasia" by people in Profiles.
-
Iwata H, Osborn EA, Ughi GJ, Murakami K, Goettsch C, Hutcheson JD, Mauskapf A, Mattson PC, Libby P, Singh SA, Matamalas J, Aikawa E, Tearney GJ, Aikawa M, Jaffer FA. Highly Selective PPAR? (Peroxisome Proliferator-Activated Receptor ?) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging. J Am Heart Assoc. 2021 10 19; 10(20):e020834.
-
Brar N, Butzmann A, Kumar J, Peerani R, Morgan EA, Grigoriadis G, Kumar B, Tatarczuch RM, Warnke RA, Ohgami RS. LIM domain only 2 (LMO2) expression distinguishes T-lymphoblastic leukemia/lymphoma from indolent T-lymphoblastic proliferations. Histopathology. 2020 Dec; 77(6):984-988.
-
Gregory KJ, Roberts AL, Conlon EM, Mayfield JA, Hagen MJ, Crisi GM, Bentley BA, Kane JJ, Makari-Judson G, Mason HS, Yu J, Zhu LJ, Simin K, Johnson JPS, Khan A, Schneider BR, Schneider SS, Jerry DJ. Gene expression signature of atypical breast hyperplasia and regulation by SFRP1. Breast Cancer Res. 2019 06 27; 21(1):76.
-
Caroff J, Iacobucci M, Rouchaud A, Mihalea C, de Carvalho FM, Jocson VED, Chalumeau V, Da Ros V, King RM, Arslanian R, Ikka L, Ben Achour N, Moret J, Spelle L. The occurrence of neointimal hyperplasia after flow-diverter implantation is associated with cardiovascular risks factors and the stent design. J Neurointerv Surg. 2019 Jun; 11(6):610-613.
-
Caroff J, Tamura T, King RM, Lylyk PN, Langan ET, Brooks OW, Clarençon F, Wainwright JM, Spelle L, Marosfoi M, Gounis MJ, Puri AS. Phosphorylcholine surface modified flow diverter associated with reduced intimal hyperplasia. J Neurointerv Surg. 2018 Nov; 10(11):1097-1101.
-
Pyxaras SA, Adriaenssens T, Barbato E, Ughi GJ, Di Serafino L, De Vroey F, Toth G, Tu S, Reiber JHC, Bax JJ, Wijns W. In-stent fractional flow reserve variations and related optical coherence tomography findings: the FFR-OCT co-registration study. Int J Cardiovasc Imaging. 2018 Apr; 34(4):495-502.
-
Linsk A, Mehta TS, Dialani V, Brook A, Chadashvili T, Houlihan MJ, Sharma R. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model. Breast J. 2018 03; 24(2):115-119.
-
Fullington NM, Potanos KM, Cauley RP, Purcell P, Zurakowski D, Fishman SJ, Vakili K, Kim HB. Strain induced esophageal growth in a novel rodent model. J Pediatr Surg. 2016 Aug; 51(8):1273-8.
-
Kayyali US, Larsen CG, Bashiruddin S, Lewandowski SL, Trivedi CM, Warburton RR, Parkhitko AA, Morrison TA, Henske EP, Chekaluk Y, Kwiatkowski DJ, Finlay GA. Targeted deletion of Tsc1 causes fatal cardiomyocyte hyperplasia independently of afterload. Cardiovasc Pathol. 2015 Mar-Apr; 24(2):80-93.
-
Eldridge SR, Covey J, Morris J, Fang B, Horn TL, Elsass KE, Hamre JR, McCormick DL, Davis MA. Characterization of acute biliary hyperplasia in Fisher 344 rats administered the indole-3-carbinol analog, NSC-743380. Toxicol Appl Pharmacol. 2014 Dec 15; 281(3):303-9.